SlideShare a Scribd company logo
Toxicity
Testing
Mr. Jaineel Dharod
Dept. of Pharmacology
Toxicology
 Toxicology is the scientific study of adverse effects that
occur in living organisms due to chemicals.
 It involves observing and reporting symptoms, mechanisms,
detection and treatments of toxic substances, in particular
relation to poisoning of humans.
Toxicity Studies
 Acute toxicity (14 Days)
 Sub-acute (repeated doses) toxicity (28 Days)
 Sub-chronic toxicity (3 Months)
 Chronic toxicity (6 Months to 2 Years)
 Special toxicity (Carcinogenicity)
Acute Toxicity
Acute toxicity studies are conducted to determine the short-term
adverse effects of drug when administered in a single dose, or in
multiple doses during a period of 24 h in two mammalian species (one
non-rodent).
Acute Toxicity Symptoms
 Altered Respiration
 Weight loss
 Muscle spasm
 Salvation
 Convulsion
 Diarrhea
 Loss of righting reflex
 Tremor
 Lacrimation
WHAT IS LD50 ?
 LD50 represents the individual dose required to kill 50%
of a population of test animals.
 It is an index determination of medicine and poison's
virulence.
 Lower the LD 50 dose, the more toxic the pesticide.
WHAT is LC50?
 The concentrations of the chemical in air that kills 50% of
the test animals during the observation period is the LC50
value..
 Other durations of exposure (versus the traditional 4
hours) may apply depending on specific laws.
`
Methods to Determine LD50
 Karber's method
 Miller and Tainter method
 Lorke's method
 Fixed dose method
 UP and down method
 A humane endpoint can be defined as the earliest indicator
in an animal experiment of severe pain, severe distress,
suffering, or impending death.
 OECD Test Guidelines do not require death as an endpoint.
 Animals humanely killed during the test will be regarded as
dosage-dependent deaths.
 Three alternative test methods (Guidelines 420, 423,
and 425) to the traditional acute oral toxicity test have
been adopted by the OECD. One of these, the Fixed Dose
Procedure (Guideline 420).
 In vitro (test tube) test methods and models based on human cell and
tissue culture.
 Computerized patient-drug databases and virtual drug trials.
 Computer models and simulations.
 Stem cell and genetic testing methods.
 Non-invasive imaging techniques such as MRI and CT Scans.
 Microdosing (in which humans are given very low quantities of a drug to
test the effects on the body on the cellular level, without affecting the
whole body system).
Alternative approaches
Design of Acute Toxicity
 14 days study.
 Study on at least two species.
 One rodent -mice/rat. One non rodent-usually rabbit.
 Dose administered orally & parenterally. Various dose
levels to groups of both sexes.
 Dose selection such that causing than less than 50% but
not 0% and more than 50% but not 100% mortality.
Advantages
 Reproducible procedure.
 Causes less suffering to the animals.
 Uses only moderately toxic doses, doses expected to be
lethal should be avoided.
 Uses fewer animals
Two Step Procedure
1. Sighting Study
2. Main Study
Sighting
Study
Main
Study
Limitations
 Indicated that all are likely to perform poorly for chemicals
with shallow dose-response slopes Because Guideline 420
uses evident toxicity as an endpoint instead of death.
 Unusually test substances may cause delayed deaths (5
days or more after test substance administration) mostly
in case of 425
Chronic Toxicity
Chronic toxicity is the toxicity produced by a chemical or
pharmaceutical when it is exposed in long term (6-12
months)
The main objective are:
 The identification of the chronic toxicity of a chemical
 The identification of target organs
 Characterization of the dose-response relationship
 Identification of a no-observed-adverse-effect level (NOAEL).
 The prediction of chronic toxicity effects at human exposure levels
 Provision of data to test hypotheses regarding mode of action
 The original Guideline 452 was adopted in 1981.
 After revision it was adopted in 7 September 2009.
 The updating of TG 452 has been carried out in parallel with
revisions of the Test Guidelines 451 (Carcinogenicity Studies) and
453 (Combined Chronic Toxicity/Carcinogenicity studies) with the
objective of obtaining additional information from the animals used
in the study and providing further detail on dose selection.
 This Test Guideline is designed to be used in the testing of a broad
range of chemicals, including pesticides and industrial chemicals
Description of Methods:
 Animals in each group:
 Rodents: Rats, mice (M & F-20 animal each sex)
 Non Rodents-(M & F- 4 animal each sex)
 The females should be nulliparous and non-pregnant.
 Housing: In India, As per CPCSEA guideline (22°C (+ 3°C), 50-60% RH,
12 h light-dark cycle, feed with standard laboratory diet with water at
libitum).
 Preparation of Animals: The animals are randomly selected (weight
variation <20%), marked and acclimatize for at least 7 days prior to the
start of dosing to avoiding any stress.
 Dose level: Dose levels will generally based on the results of shorter
term repeated dose or range finding studies. 3 dose level (2-4 fold
interval) will used with an one control (vehicle control) group.
 Control group- vehicle treated
 Low dose level
 Mid dose level
 Higher dose level </= evident toxic dose and not more than 1000 mg/kg
 Dose preparation: oral, via gavage (10ml/kg), food or drinking water
 Vehicle: Water/corn oil
Test substance:
 physical nature, purity, and physicochemical properties;
 identification data;
 Source of substance;
 batch number;
 certificate of chemical analysis
 Vehicle (if appropriate): justification for choice of vehicle (if other than
water).
Test Report
Test animals:
 species/strain used and justification for choice made;
 number, age, and sex of animals at start of test;
 Source, housing conditions, diet, etc.
 individual weights of animals at the start of the test.
Test conditions:
 rationale for route of administration and dose selection;
 when applicable, the statistical methods used to analyse the data;
 details of test substance formulation/diet preparation:
Test Report
Test conditions:
 analytical data on achieved concentration, stability and homogeneity of
the preparation
 route of administration and details of the administration of the test
substance;
 for inhalation studies, whether nose only or whole body;
 actual doses (mg/kg body weight/day), and conversion factor from
diet/drinking water test substance concentration (mg/kg or ppm) to
the actual dose, if applicable:
 details of food and water quality.
Test Report
Results:
 survival data;
 body weight/body weight changes;
 food consumption, and water consumption if applicable;
 toxic response data by sex and dose level, including signs of toxicity;
 nature, incidence (and, if scored, severity), and duration of clinical
observations (whether transitory or permanent);
 ophthalmological examination;
 haematological tests;
Test Report
Results:
 clinical biochemistry tests;
 Urine analysis tests;
 outcome of any investigations of neurotoxicity or immunotoxicity
 terminal body weight;
 organ weights (and their ratios, if applicable);
 necropsy findings:
 detailed description of all treatment-related histopathological findings:
 Absorption data if available;
 Statistical treatment of results, as appropriate
Test Report
Discussion of results including:
 Dose - response relationships
 Consideration of any mode of action information
 Discussion of any modelling approaches
 BMD, NOAEL or LOAEL determination
 Historical control data
 Relevance for humans
Conclusion
Test Report

More Related Content

Similar to toxicitytesting-200920120607.pdf

Subacute toxicity testing as per oecd guidelines tulsi 407
Subacute toxicity testing as per oecd guidelines tulsi 407Subacute toxicity testing as per oecd guidelines tulsi 407
Subacute toxicity testing as per oecd guidelines tulsi 407
Tulsi Gulabrao Patil
 
Experimental Techniques For Evaluation Of New Drugs.ppt
Experimental Techniques For Evaluation Of New Drugs.pptExperimental Techniques For Evaluation Of New Drugs.ppt
Experimental Techniques For Evaluation Of New Drugs.ppt
KarabiAdak
 
OECD Guidelines
OECD GuidelinesOECD Guidelines
OECD Guidelines
Urmila Aswar
 
Introduction to toxicology
Introduction to toxicologyIntroduction to toxicology
Introduction to toxicology
ManojKumar109262
 
ACUTE, SUB ACUTE & CHRONIC TOXICOLOGICAL STUDIES
ACUTE, SUB ACUTE & CHRONIC TOXICOLOGICAL STUDIESACUTE, SUB ACUTE & CHRONIC TOXICOLOGICAL STUDIES
ACUTE, SUB ACUTE & CHRONIC TOXICOLOGICAL STUDIES
Dr. Sindhu K., Asst. Prof., Dept. of VPT, VCG.
 
chronic dermal and inhalational studies as per OECD
chronic dermal and inhalational studies as per OECDchronic dermal and inhalational studies as per OECD
chronic dermal and inhalational studies as per OECD
Sohil Shah
 
OECD Guideline 420: Acute oral Toxicity - Fixed Dose Procedure
OECD Guideline 420: Acute oral Toxicity - Fixed Dose ProcedureOECD Guideline 420: Acute oral Toxicity - Fixed Dose Procedure
OECD Guideline 420: Acute oral Toxicity - Fixed Dose Procedure
KhushbooThakur15
 
Subacute toxicity
Subacute toxicitySubacute toxicity
Subacute toxicityvaniarlekar
 
chronic toxicity studies
chronic toxicity studieschronic toxicity studies
chronic toxicity studies
karan chainani
 
OECD Dermal testing By Priya.pptx
OECD Dermal testing By Priya.pptxOECD Dermal testing By Priya.pptx
OECD Dermal testing By Priya.pptx
Priya818982
 
REPRODUCTIVE TOXICITY STUDIE OF MALE AND FEMALEpptx
REPRODUCTIVE TOXICITY  STUDIE OF MALE AND FEMALEpptxREPRODUCTIVE TOXICITY  STUDIE OF MALE AND FEMALEpptx
REPRODUCTIVE TOXICITY STUDIE OF MALE AND FEMALEpptx
manishaJyala2
 
Sub acute
Sub acuteSub acute
Principles of Toxicology
Principles of ToxicologyPrinciples of Toxicology
Principles of Toxicology
vadivelan2017
 
Oecd guidelines
Oecd guidelinesOecd guidelines
Oecd guidelines
Umangi Thakkar
 
Animal toxicity.pptx
Animal toxicity.pptxAnimal toxicity.pptx
Animal toxicity.pptx
SaakshiDeokar
 
Acute and chronic toxicity studies in animals
Acute and chronic toxicity studies in animalsAcute and chronic toxicity studies in animals
Acute and chronic toxicity studies in animals
SwaroopaNallabariki
 
Reproductive toxicology
Reproductive toxicologyReproductive toxicology
Reproductive toxicology
Khadga Raj
 
Male and female reproductive toxicology
Male and female reproductive toxicologyMale and female reproductive toxicology
Male and female reproductive toxicology
Khadga Raj
 
Preclinical testing - An intro
Preclinical testing -  An introPreclinical testing -  An intro
Preclinical testing - An intro
samthamby79
 

Similar to toxicitytesting-200920120607.pdf (20)

Subacute toxicity testing as per oecd guidelines tulsi 407
Subacute toxicity testing as per oecd guidelines tulsi 407Subacute toxicity testing as per oecd guidelines tulsi 407
Subacute toxicity testing as per oecd guidelines tulsi 407
 
Experimental Techniques For Evaluation Of New Drugs.ppt
Experimental Techniques For Evaluation Of New Drugs.pptExperimental Techniques For Evaluation Of New Drugs.ppt
Experimental Techniques For Evaluation Of New Drugs.ppt
 
OECD Guidelines
OECD GuidelinesOECD Guidelines
OECD Guidelines
 
Introduction to toxicology
Introduction to toxicologyIntroduction to toxicology
Introduction to toxicology
 
ACUTE, SUB ACUTE & CHRONIC TOXICOLOGICAL STUDIES
ACUTE, SUB ACUTE & CHRONIC TOXICOLOGICAL STUDIESACUTE, SUB ACUTE & CHRONIC TOXICOLOGICAL STUDIES
ACUTE, SUB ACUTE & CHRONIC TOXICOLOGICAL STUDIES
 
chronic dermal and inhalational studies as per OECD
chronic dermal and inhalational studies as per OECDchronic dermal and inhalational studies as per OECD
chronic dermal and inhalational studies as per OECD
 
OECD Guideline 420: Acute oral Toxicity - Fixed Dose Procedure
OECD Guideline 420: Acute oral Toxicity - Fixed Dose ProcedureOECD Guideline 420: Acute oral Toxicity - Fixed Dose Procedure
OECD Guideline 420: Acute oral Toxicity - Fixed Dose Procedure
 
Subacute toxicity
Subacute toxicitySubacute toxicity
Subacute toxicity
 
chronic toxicity studies
chronic toxicity studieschronic toxicity studies
chronic toxicity studies
 
OECD Dermal testing By Priya.pptx
OECD Dermal testing By Priya.pptxOECD Dermal testing By Priya.pptx
OECD Dermal testing By Priya.pptx
 
REPRODUCTIVE TOXICITY STUDIE OF MALE AND FEMALEpptx
REPRODUCTIVE TOXICITY  STUDIE OF MALE AND FEMALEpptxREPRODUCTIVE TOXICITY  STUDIE OF MALE AND FEMALEpptx
REPRODUCTIVE TOXICITY STUDIE OF MALE AND FEMALEpptx
 
Sub acute
Sub acuteSub acute
Sub acute
 
Principles of Toxicology
Principles of ToxicologyPrinciples of Toxicology
Principles of Toxicology
 
Toxicological screening
Toxicological screeningToxicological screening
Toxicological screening
 
Oecd guidelines
Oecd guidelinesOecd guidelines
Oecd guidelines
 
Animal toxicity.pptx
Animal toxicity.pptxAnimal toxicity.pptx
Animal toxicity.pptx
 
Acute and chronic toxicity studies in animals
Acute and chronic toxicity studies in animalsAcute and chronic toxicity studies in animals
Acute and chronic toxicity studies in animals
 
Reproductive toxicology
Reproductive toxicologyReproductive toxicology
Reproductive toxicology
 
Male and female reproductive toxicology
Male and female reproductive toxicologyMale and female reproductive toxicology
Male and female reproductive toxicology
 
Preclinical testing - An intro
Preclinical testing -  An introPreclinical testing -  An intro
Preclinical testing - An intro
 

More from ChijiokeNsofor

BTC 509 Intersection of AI and Biotechnolog.pptx
BTC 509 Intersection of AI and Biotechnolog.pptxBTC 509 Intersection of AI and Biotechnolog.pptx
BTC 509 Intersection of AI and Biotechnolog.pptx
ChijiokeNsofor
 
BTC 810 Mass spectrometry and it applications.ppt
BTC 810 Mass spectrometry and it applications.pptBTC 810 Mass spectrometry and it applications.ppt
BTC 810 Mass spectrometry and it applications.ppt
ChijiokeNsofor
 
Work Report- October 2021.pptx
Work Report- October 2021.pptxWork Report- October 2021.pptx
Work Report- October 2021.pptx
ChijiokeNsofor
 
FRS 310 Bite mark evidence.ppt
FRS 310 Bite mark evidence.pptFRS 310 Bite mark evidence.ppt
FRS 310 Bite mark evidence.ppt
ChijiokeNsofor
 
Project Report.pptx
Project Report.pptxProject Report.pptx
Project Report.pptx
ChijiokeNsofor
 
cells of immune system.ppt
cells of immune system.pptcells of immune system.ppt
cells of immune system.ppt
ChijiokeNsofor
 
FRS 301 Analysis of biological fluids.pptx
FRS 301 Analysis of biological fluids.pptxFRS 301 Analysis of biological fluids.pptx
FRS 301 Analysis of biological fluids.pptx
ChijiokeNsofor
 
BTC 810 Analysis of Transcriptomes.pptx
BTC 810 Analysis of Transcriptomes.pptxBTC 810 Analysis of Transcriptomes.pptx
BTC 810 Analysis of Transcriptomes.pptx
ChijiokeNsofor
 
FRS 411-POST MORTEM CHANGES.ppt
FRS 411-POST MORTEM CHANGES.pptFRS 411-POST MORTEM CHANGES.ppt
FRS 411-POST MORTEM CHANGES.ppt
ChijiokeNsofor
 
FRS 411-Death.pptx
FRS 411-Death.pptxFRS 411-Death.pptx
FRS 411-Death.pptx
ChijiokeNsofor
 
FRS 310 Bite mark.pptx
FRS 310 Bite mark.pptxFRS 310 Bite mark.pptx
FRS 310 Bite mark.pptx
ChijiokeNsofor
 
antibody engineering.ppt
antibody engineering.pptantibody engineering.ppt
antibody engineering.ppt
ChijiokeNsofor
 
BTC 506 Phylogenetic Tree.pptx
BTC 506 Phylogenetic Tree.pptxBTC 506 Phylogenetic Tree.pptx
BTC 506 Phylogenetic Tree.pptx
ChijiokeNsofor
 
FRS 304 Forensic Anthropology-Introduction.pptx
FRS 304 Forensic Anthropology-Introduction.pptxFRS 304 Forensic Anthropology-Introduction.pptx
FRS 304 Forensic Anthropology-Introduction.pptx
ChijiokeNsofor
 
cells of immune system.ppt
cells of immune system.pptcells of immune system.ppt
cells of immune system.ppt
ChijiokeNsofor
 
BTC 506 Gene Identification using Bioinformatic Tools-230302130331.pptx
BTC 506 Gene Identification using Bioinformatic Tools-230302130331.pptxBTC 506 Gene Identification using Bioinformatic Tools-230302130331.pptx
BTC 506 Gene Identification using Bioinformatic Tools-230302130331.pptx
ChijiokeNsofor
 
bioassay.pdf
bioassay.pdfbioassay.pdf
bioassay.pdf
ChijiokeNsofor
 
BTC 506 Phylogenetic Analysis.pptx
BTC 506 Phylogenetic Analysis.pptxBTC 506 Phylogenetic Analysis.pptx
BTC 506 Phylogenetic Analysis.pptx
ChijiokeNsofor
 
cancer prevention.pptx
cancer prevention.pptxcancer prevention.pptx
cancer prevention.pptx
ChijiokeNsofor
 
bioassay-converted.pptx
bioassay-converted.pptxbioassay-converted.pptx
bioassay-converted.pptx
ChijiokeNsofor
 

More from ChijiokeNsofor (20)

BTC 509 Intersection of AI and Biotechnolog.pptx
BTC 509 Intersection of AI and Biotechnolog.pptxBTC 509 Intersection of AI and Biotechnolog.pptx
BTC 509 Intersection of AI and Biotechnolog.pptx
 
BTC 810 Mass spectrometry and it applications.ppt
BTC 810 Mass spectrometry and it applications.pptBTC 810 Mass spectrometry and it applications.ppt
BTC 810 Mass spectrometry and it applications.ppt
 
Work Report- October 2021.pptx
Work Report- October 2021.pptxWork Report- October 2021.pptx
Work Report- October 2021.pptx
 
FRS 310 Bite mark evidence.ppt
FRS 310 Bite mark evidence.pptFRS 310 Bite mark evidence.ppt
FRS 310 Bite mark evidence.ppt
 
Project Report.pptx
Project Report.pptxProject Report.pptx
Project Report.pptx
 
cells of immune system.ppt
cells of immune system.pptcells of immune system.ppt
cells of immune system.ppt
 
FRS 301 Analysis of biological fluids.pptx
FRS 301 Analysis of biological fluids.pptxFRS 301 Analysis of biological fluids.pptx
FRS 301 Analysis of biological fluids.pptx
 
BTC 810 Analysis of Transcriptomes.pptx
BTC 810 Analysis of Transcriptomes.pptxBTC 810 Analysis of Transcriptomes.pptx
BTC 810 Analysis of Transcriptomes.pptx
 
FRS 411-POST MORTEM CHANGES.ppt
FRS 411-POST MORTEM CHANGES.pptFRS 411-POST MORTEM CHANGES.ppt
FRS 411-POST MORTEM CHANGES.ppt
 
FRS 411-Death.pptx
FRS 411-Death.pptxFRS 411-Death.pptx
FRS 411-Death.pptx
 
FRS 310 Bite mark.pptx
FRS 310 Bite mark.pptxFRS 310 Bite mark.pptx
FRS 310 Bite mark.pptx
 
antibody engineering.ppt
antibody engineering.pptantibody engineering.ppt
antibody engineering.ppt
 
BTC 506 Phylogenetic Tree.pptx
BTC 506 Phylogenetic Tree.pptxBTC 506 Phylogenetic Tree.pptx
BTC 506 Phylogenetic Tree.pptx
 
FRS 304 Forensic Anthropology-Introduction.pptx
FRS 304 Forensic Anthropology-Introduction.pptxFRS 304 Forensic Anthropology-Introduction.pptx
FRS 304 Forensic Anthropology-Introduction.pptx
 
cells of immune system.ppt
cells of immune system.pptcells of immune system.ppt
cells of immune system.ppt
 
BTC 506 Gene Identification using Bioinformatic Tools-230302130331.pptx
BTC 506 Gene Identification using Bioinformatic Tools-230302130331.pptxBTC 506 Gene Identification using Bioinformatic Tools-230302130331.pptx
BTC 506 Gene Identification using Bioinformatic Tools-230302130331.pptx
 
bioassay.pdf
bioassay.pdfbioassay.pdf
bioassay.pdf
 
BTC 506 Phylogenetic Analysis.pptx
BTC 506 Phylogenetic Analysis.pptxBTC 506 Phylogenetic Analysis.pptx
BTC 506 Phylogenetic Analysis.pptx
 
cancer prevention.pptx
cancer prevention.pptxcancer prevention.pptx
cancer prevention.pptx
 
bioassay-converted.pptx
bioassay-converted.pptxbioassay-converted.pptx
bioassay-converted.pptx
 

Recently uploaded

Introduction to Quality Improvement Essentials
Introduction to Quality Improvement EssentialsIntroduction to Quality Improvement Essentials
Introduction to Quality Improvement Essentials
Excellence Foundation for South Sudan
 
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptx
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptxStudents, digital devices and success - Andreas Schleicher - 27 May 2024..pptx
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptx
EduSkills OECD
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
EugeneSaldivar
 
Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)
rosedainty
 
How to Break the cycle of negative Thoughts
How to Break the cycle of negative ThoughtsHow to Break the cycle of negative Thoughts
How to Break the cycle of negative Thoughts
Col Mukteshwar Prasad
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
Jisc
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
beazzy04
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
Pavel ( NSTU)
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
Celine George
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 
Fish and Chips - have they had their chips
Fish and Chips - have they had their chipsFish and Chips - have they had their chips
Fish and Chips - have they had their chips
GeoBlogs
 
The Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdfThe Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdf
kaushalkr1407
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
EverAndrsGuerraGuerr
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
Vikramjit Singh
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
Delapenabediema
 
The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
GeoBlogs
 
Polish students' mobility in the Czech Republic
Polish students' mobility in the Czech RepublicPolish students' mobility in the Czech Republic
Polish students' mobility in the Czech Republic
Anna Sz.
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
DeeptiGupta154
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
joachimlavalley1
 
How to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS ModuleHow to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS Module
Celine George
 

Recently uploaded (20)

Introduction to Quality Improvement Essentials
Introduction to Quality Improvement EssentialsIntroduction to Quality Improvement Essentials
Introduction to Quality Improvement Essentials
 
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptx
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptxStudents, digital devices and success - Andreas Schleicher - 27 May 2024..pptx
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptx
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
 
Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)
 
How to Break the cycle of negative Thoughts
How to Break the cycle of negative ThoughtsHow to Break the cycle of negative Thoughts
How to Break the cycle of negative Thoughts
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 
Fish and Chips - have they had their chips
Fish and Chips - have they had their chipsFish and Chips - have they had their chips
Fish and Chips - have they had their chips
 
The Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdfThe Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdf
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
 
The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
 
Polish students' mobility in the Czech Republic
Polish students' mobility in the Czech RepublicPolish students' mobility in the Czech Republic
Polish students' mobility in the Czech Republic
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
 
How to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS ModuleHow to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS Module
 

toxicitytesting-200920120607.pdf

  • 2. Toxicology  Toxicology is the scientific study of adverse effects that occur in living organisms due to chemicals.  It involves observing and reporting symptoms, mechanisms, detection and treatments of toxic substances, in particular relation to poisoning of humans.
  • 3. Toxicity Studies  Acute toxicity (14 Days)  Sub-acute (repeated doses) toxicity (28 Days)  Sub-chronic toxicity (3 Months)  Chronic toxicity (6 Months to 2 Years)  Special toxicity (Carcinogenicity)
  • 4. Acute Toxicity Acute toxicity studies are conducted to determine the short-term adverse effects of drug when administered in a single dose, or in multiple doses during a period of 24 h in two mammalian species (one non-rodent).
  • 5. Acute Toxicity Symptoms  Altered Respiration  Weight loss  Muscle spasm  Salvation  Convulsion  Diarrhea  Loss of righting reflex  Tremor  Lacrimation
  • 6. WHAT IS LD50 ?  LD50 represents the individual dose required to kill 50% of a population of test animals.  It is an index determination of medicine and poison's virulence.  Lower the LD 50 dose, the more toxic the pesticide.
  • 7. WHAT is LC50?  The concentrations of the chemical in air that kills 50% of the test animals during the observation period is the LC50 value..  Other durations of exposure (versus the traditional 4 hours) may apply depending on specific laws.
  • 8.
  • 9. `
  • 10.
  • 11.
  • 12. Methods to Determine LD50  Karber's method  Miller and Tainter method  Lorke's method  Fixed dose method  UP and down method
  • 13.  A humane endpoint can be defined as the earliest indicator in an animal experiment of severe pain, severe distress, suffering, or impending death.  OECD Test Guidelines do not require death as an endpoint.  Animals humanely killed during the test will be regarded as dosage-dependent deaths.  Three alternative test methods (Guidelines 420, 423, and 425) to the traditional acute oral toxicity test have been adopted by the OECD. One of these, the Fixed Dose Procedure (Guideline 420).
  • 14.
  • 15.  In vitro (test tube) test methods and models based on human cell and tissue culture.  Computerized patient-drug databases and virtual drug trials.  Computer models and simulations.  Stem cell and genetic testing methods.  Non-invasive imaging techniques such as MRI and CT Scans.  Microdosing (in which humans are given very low quantities of a drug to test the effects on the body on the cellular level, without affecting the whole body system). Alternative approaches
  • 16.
  • 17. Design of Acute Toxicity  14 days study.  Study on at least two species.  One rodent -mice/rat. One non rodent-usually rabbit.  Dose administered orally & parenterally. Various dose levels to groups of both sexes.  Dose selection such that causing than less than 50% but not 0% and more than 50% but not 100% mortality.
  • 18. Advantages  Reproducible procedure.  Causes less suffering to the animals.  Uses only moderately toxic doses, doses expected to be lethal should be avoided.  Uses fewer animals
  • 19. Two Step Procedure 1. Sighting Study 2. Main Study
  • 22. Limitations  Indicated that all are likely to perform poorly for chemicals with shallow dose-response slopes Because Guideline 420 uses evident toxicity as an endpoint instead of death.  Unusually test substances may cause delayed deaths (5 days or more after test substance administration) mostly in case of 425
  • 23. Chronic Toxicity Chronic toxicity is the toxicity produced by a chemical or pharmaceutical when it is exposed in long term (6-12 months)
  • 24. The main objective are:  The identification of the chronic toxicity of a chemical  The identification of target organs  Characterization of the dose-response relationship  Identification of a no-observed-adverse-effect level (NOAEL).  The prediction of chronic toxicity effects at human exposure levels  Provision of data to test hypotheses regarding mode of action
  • 25.  The original Guideline 452 was adopted in 1981.  After revision it was adopted in 7 September 2009.  The updating of TG 452 has been carried out in parallel with revisions of the Test Guidelines 451 (Carcinogenicity Studies) and 453 (Combined Chronic Toxicity/Carcinogenicity studies) with the objective of obtaining additional information from the animals used in the study and providing further detail on dose selection.  This Test Guideline is designed to be used in the testing of a broad range of chemicals, including pesticides and industrial chemicals
  • 26.
  • 27. Description of Methods:  Animals in each group:  Rodents: Rats, mice (M & F-20 animal each sex)  Non Rodents-(M & F- 4 animal each sex)  The females should be nulliparous and non-pregnant.  Housing: In India, As per CPCSEA guideline (22°C (+ 3°C), 50-60% RH, 12 h light-dark cycle, feed with standard laboratory diet with water at libitum).  Preparation of Animals: The animals are randomly selected (weight variation <20%), marked and acclimatize for at least 7 days prior to the start of dosing to avoiding any stress.
  • 28.  Dose level: Dose levels will generally based on the results of shorter term repeated dose or range finding studies. 3 dose level (2-4 fold interval) will used with an one control (vehicle control) group.  Control group- vehicle treated  Low dose level  Mid dose level  Higher dose level </= evident toxic dose and not more than 1000 mg/kg  Dose preparation: oral, via gavage (10ml/kg), food or drinking water  Vehicle: Water/corn oil
  • 29. Test substance:  physical nature, purity, and physicochemical properties;  identification data;  Source of substance;  batch number;  certificate of chemical analysis  Vehicle (if appropriate): justification for choice of vehicle (if other than water). Test Report
  • 30. Test animals:  species/strain used and justification for choice made;  number, age, and sex of animals at start of test;  Source, housing conditions, diet, etc.  individual weights of animals at the start of the test. Test conditions:  rationale for route of administration and dose selection;  when applicable, the statistical methods used to analyse the data;  details of test substance formulation/diet preparation: Test Report
  • 31. Test conditions:  analytical data on achieved concentration, stability and homogeneity of the preparation  route of administration and details of the administration of the test substance;  for inhalation studies, whether nose only or whole body;  actual doses (mg/kg body weight/day), and conversion factor from diet/drinking water test substance concentration (mg/kg or ppm) to the actual dose, if applicable:  details of food and water quality. Test Report
  • 32. Results:  survival data;  body weight/body weight changes;  food consumption, and water consumption if applicable;  toxic response data by sex and dose level, including signs of toxicity;  nature, incidence (and, if scored, severity), and duration of clinical observations (whether transitory or permanent);  ophthalmological examination;  haematological tests; Test Report
  • 33. Results:  clinical biochemistry tests;  Urine analysis tests;  outcome of any investigations of neurotoxicity or immunotoxicity  terminal body weight;  organ weights (and their ratios, if applicable);  necropsy findings:  detailed description of all treatment-related histopathological findings:  Absorption data if available;  Statistical treatment of results, as appropriate Test Report
  • 34. Discussion of results including:  Dose - response relationships  Consideration of any mode of action information  Discussion of any modelling approaches  BMD, NOAEL or LOAEL determination  Historical control data  Relevance for humans Conclusion Test Report